Press Releases

Our latest news and press releases

All 2024 2023 2022 2021 2020

02 May 2023
12:05 E.S.T.

Cellectis Announces Oral Presentation on AMELI-01 and Poster Presentation on Multiplex Engineering for Superior Generation of CAR T-cells at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

27 Apr 2023
10:01 E.S.T.

Cellectis to Report First Quarter 2023 Financial Results on May 4, 2023

24 Apr 2023
11:39 E.S.T.

Cellectis Implements CLLS52 for the First Time in the Clinic with Sanofi’s Alemtuzumab

17 Apr 2023
02:00 E.S.T.

Cellectis Presents Preclinical Data on TALEN®-edited MUC1 CAR T-cells to Enhance Efficacy in Targeting Triple Negative Breast Cancer at the American Association for Cancer Research (AACR) Annual Meeting

11 Apr 2023
16:30 E.S.T.

Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UCART22

04 Apr 2023
16:30 E.S.T.

Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreement and announces the drawdown of the first tranche of €20 million

Prev 3 4 5 6 7 Next